Clonidine



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 30.6%
Product Used For Unknown Indication 17.0%
Drug Use For Unknown Indication 8.9%
Blood Pressure Increased 7.7%
Pain 4.6%
Epidural Anaesthesia 3.2%
Postoperative Analgesia 3.0%
Attention Deficit/hyperactivity Disorder 2.9%
Nerve Block 2.9%
Analgesic Therapy 2.4%
Blood Pressure 2.2%
Induction Of Anaesthesia 2.0%
Neuralgia 1.8%
Spinal Anaesthesia 1.8%
Tourette's Disorder 1.7%
Cancer Pain 1.6%
Back Pain 1.4%
Sedative Therapy 1.4%
Anaesthetic Premedication 1.4%
Bipolar Disorder 1.3%
Product Substitution Issue 10.9%
Completed Suicide 10.7%
Drug Ineffective 8.7%
Hypotension 8.1%
Death 7.2%
Poisoning 6.8%
Blood Pressure Increased 5.5%
Somnolence 5.2%
Product Adhesion Issue 4.8%
Product Quality Issue 4.1%
Application Site Erythema 3.3%
Vomiting 3.3%
Hypertension 3.1%
Overdose 3.1%
Cardio-respiratory Arrest 2.8%
Respiratory Arrest 2.8%
Tachycardia 2.6%
Syncope 2.4%
Toxicity To Various Agents 2.4%
Application Site Pruritus 2.2%
Secondary
Product Used For Unknown Indication 29.5%
Hypertension 20.5%
Drug Use For Unknown Indication 16.1%
Pain 8.3%
Attention Deficit/hyperactivity Disorder 3.8%
Spinal Anaesthesia 3.3%
Neuralgia 2.0%
Suicide Attempt 2.0%
Blood Pressure Increased 1.8%
Bipolar Disorder 1.6%
Cancer Pain 1.5%
Depression 1.3%
Anaesthesia 1.2%
Complex Regional Pain Syndrome 1.2%
Blood Pressure 1.1%
Dehydration 1.1%
Hyperlipidaemia 1.0%
Agitation 0.9%
Diabetes Mellitus 0.9%
Completed Suicide 0.8%
Completed Suicide 17.9%
Hypotension 10.5%
Death 9.4%
Vomiting 7.1%
Respiratory Arrest 5.9%
Overdose 4.9%
Poisoning 4.9%
Toxicity To Various Agents 4.7%
Drug Ineffective 4.0%
Blood Pressure Increased 3.8%
Drug Toxicity 3.3%
Hypertension 3.2%
Suicide Attempt 3.2%
Somnolence 2.9%
Weight Increased 2.7%
Vertigo 2.6%
Pain 2.3%
Syncope 2.3%
Unresponsive To Stimuli 2.3%
Intentional Drug Misuse 2.1%
Concomitant
Product Used For Unknown Indication 29.4%
Drug Use For Unknown Indication 21.1%
Hypertension 16.9%
Pain 4.5%
Diabetes Mellitus 3.1%
Depression 3.0%
Anxiety 2.2%
Blood Pressure 2.2%
Nuclear Magnetic Resonance Imaging 2.1%
Rheumatoid Arthritis 1.8%
Blood Cholesterol Increased 1.7%
Gastrooesophageal Reflux Disease 1.6%
Attention Deficit/hyperactivity Disorder 1.5%
Insomnia 1.4%
Type 2 Diabetes Mellitus 1.4%
Bipolar Disorder 1.4%
Multiple Myeloma 1.3%
Asthma 1.3%
Prophylaxis 1.2%
Prophylaxis Against Transplant Rejection 1.0%
Vomiting 14.6%
Weight Decreased 9.8%
Weight Increased 9.5%
Pain 6.2%
Drug Ineffective 5.2%
Death 4.4%
Myocardial Infarction 4.3%
Vision Blurred 4.1%
Urinary Tract Infection 4.1%
Nausea 4.1%
Hypertension 3.9%
Tremor 3.9%
Type 2 Diabetes Mellitus 3.8%
Renal Failure 3.7%
Pneumonia 3.6%
Somnolence 3.3%
Renal Failure Acute 3.0%
Dyspnoea 2.9%
Wrong Technique In Drug Usage Process 2.8%
Oedema Peripheral 2.7%
Interacting
Product Used For Unknown Indication 31.5%
Drug Use For Unknown Indication 20.6%
Hypertension 8.5%
Blood Pressure 6.1%
Heart Rate 3.6%
Depression 3.0%
General Anaesthesia 3.0%
Anaesthesia 2.4%
Anxiety 2.4%
Dementia 2.4%
Mania 2.4%
Neuropathy Peripheral 2.4%
Prophylaxis 2.4%
Asthma 1.8%
Agitation 1.2%
Back Pain 1.2%
Dyspepsia 1.2%
Gastrooesophageal Reflux Disease 1.2%
Musculoskeletal Pain 1.2%
Pain 1.2%
White Blood Cell Count Increased 10.3%
Drug Interaction 6.9%
Dysphemia 6.9%
Hypertension 6.9%
Medication Error 6.9%
Pyrexia 6.9%
Renal Failure Acute 6.9%
Tinnitus 6.9%
Disorientation 3.4%
Gait Disturbance 3.4%
Heart Rate Increased 3.4%
Hypotension 3.4%
Inhibitory Drug Interaction 3.4%
Mental Disorder 3.4%
Peritonitis 3.4%
Potentiating Drug Interaction 3.4%
Sinus Bradycardia 3.4%
Swollen Tongue 3.4%
Syncope 3.4%
Thinking Abnormal 3.4%